Current Report Filing (8-k)
September 25 2017 - 1:13PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported) September 25, 2017
MEDIFIRST
SOLUTIONS, INC.
(Exact name of registrant as specified in its
charter)
Nevada
|
|
333-178825
|
|
27-3888260
|
State or other jurisdiction incorporation
|
|
Commission File Number
|
|
IRS Employer Identification No.
|
|
|
|
|
|
4400 Route 9 South, Suite 1000, Freehold, NJ
07728
(Address of principal executive offices) (Zip
Code)
Registrant's telephone number, including area code: (732)-786-8044
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
Section
5- Corporate Governance and Management
Item 5.03
|
|
Amendment to Articles of Incorporation or Bylaws; Change of Fiscal Year
|
Effective
September 19, 2017, the Company amended its Articles of Incorporation to increase its authorized Common Stock to 4,000,000,000
shares. All other provisions of the Articles of Incorporation in effect prior to this amendment remain unchanged.
Signatures
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this amended report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
MEDIFIRST SOLUTIONS, INC.
|
|
|
Dated: September 25, 2017
|
By:
|
/s/ /s/
Bruce Schoengood
|
|
|
President and Chief Executive Officer
|